drugset / Trial / NCT01161472
A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects
RandomizedCrossoverQuadruple-blind
Summary
The study is designed to evaluate elements of cognitive function in subjects receiving either fesoterodine or alprazolam.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alprazolam | Small molecule | 1 mg | — |
| Subject | Fesoterodine | Other / unclassified | 4 mg | — |
| Subject | Fesoterodine | Other / unclassified | 8 mg | — |
Indications
No indication recorded.